-
Add to Cart The item has been addedAb170726-5mgTalquetamab (anti-GPRC5D) is a humanized bispecific antibody that binds to GPRC5D (member of G protein-coupled receptor family C5 group D) and CD3 to induce T cell-mediated killing of GPRC5D-expressing MM cells through T cell recruitment and -
Add to Cart The item has been addedAb176086-100μgTelazorlimab (anti-TNFRSF4) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab (anti-TNFRSF4) can be used for the research of autoimmune diseases.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb176086-10mgTelazorlimab (anti-TNFRSF4) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab (anti-TNFRSF4) can be used for the research of autoimmune diseases.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb176086-1mgTelazorlimab (anti-TNFRSF4) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab (anti-TNFRSF4) can be used for the research of autoimmune diseases.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb176086-5mgTelazorlimab (anti-TNFRSF4) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab (anti-TNFRSF4) can be used for the research of autoimmune diseases.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb170781-100μgTeplizumab (anti-CD3e) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab (anti-CD3e) reduces the loss of beta-cell function. Teplizumab (anti-CD3e) can be used in the research of type 1 diabetes.Purity>95% -
Add to Cart The item has been addedAb170781-10mgTeplizumab (anti-CD3e) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab (anti-CD3e) reduces the loss of beta-cell function. Teplizumab (anti-CD3e) can be used in the research of type 1 diabetes.Purity>95% -
Add to Cart The item has been addedAb170781-1mgTeplizumab (anti-CD3e) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab (anti-CD3e) reduces the loss of beta-cell function. Teplizumab (anti-CD3e) can be used in the research of type 1 diabetes.Purity>95% -
Add to Cart The item has been addedAb170781-5mgTeplizumab (anti-CD3e) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab (anti-CD3e) reduces the loss of beta-cell function. Teplizumab (anti-CD3e) can be used in the research of type 1 diabetes.Purity>95% -
Add to Cart The item has been addedAb170834-100μgTeprotumumab (anti-IGF1R) is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab (anti-IGF1R) binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab (anti-IGF1R) inhibits TSH and IGF-1 action in -
Add to Cart The item has been addedAb170834-10mgTeprotumumab (anti-IGF1R) is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab (anti-IGF1R) binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab (anti-IGF1R) inhibits TSH and IGF-1 action in -
Add to Cart The item has been addedAb170834-1mgTeprotumumab (anti-IGF1R) is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab (anti-IGF1R) binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab (anti-IGF1R) inhibits TSH and IGF-1 action in
